ASTH vs. FCN, G, EXPO, ICFI, HURN, MEG, RMR, HCKT, BWMN, and III
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include FTI Consulting (FCN), Genpact (G), Exponent (EXPO), ICF International (ICFI), Huron Consulting Group (HURN), Montrose Environmental Group (MEG), The RMR Group (RMR), The Hackett Group (HCKT), Bowman Consulting Group (BWMN), and Information Services Group (III). These companies are all part of the "management consulting services" industry.
Astrana Health (NASDAQ:ASTH) and FTI Consulting (NYSE:FCN) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.
In the previous week, Astrana Health and Astrana Health both had 3 articles in the media. FTI Consulting's average media sentiment score of 0.92 beat Astrana Health's score of 0.00 indicating that FTI Consulting is being referred to more favorably in the news media.
Astrana Health has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, FTI Consulting has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500.
Astrana Health currently has a consensus target price of $48.25, indicating a potential upside of 21.41%. FTI Consulting has a consensus target price of $255.00, indicating a potential upside of 20.85%. Given Astrana Health's higher possible upside, research analysts plainly believe Astrana Health is more favorable than FTI Consulting.
FTI Consulting received 227 more outperform votes than Astrana Health when rated by MarketBeat users. However, 75.00% of users gave Astrana Health an outperform vote while only 54.37% of users gave FTI Consulting an outperform vote.
FTI Consulting has a net margin of 8.51% compared to Astrana Health's net margin of 4.29%. FTI Consulting's return on equity of 15.97% beat Astrana Health's return on equity.
FTI Consulting has higher revenue and earnings than Astrana Health. FTI Consulting is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.
52.8% of Astrana Health shares are held by institutional investors. Comparatively, 99.4% of FTI Consulting shares are held by institutional investors. 8.5% of Astrana Health shares are held by insiders. Comparatively, 2.5% of FTI Consulting shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
FTI Consulting beats Astrana Health on 10 of the 17 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Astrana Health Competitors List
Related Companies and Tools
